OTTAWA, ON, May 12, 2025 /CNW/ – New data released today by Statistics Canada confirms that Canada’s innovative pharmaceutical industry is more than a contributor to health, it is a driver of national economic growth and resilience.
The industry contributed $18.4 billion in 2022 in total economic activity, marking a nearly 15% increase over 2021. It also invested up to $3.2 billion in R&D and supported more than 110,000 full-time jobs across the country—an almost 8% increase in jobs over the previous year.
